National Institute for Health and Care Excellence1d
Groundbreaking one-off gene therapy approved for severe sickle cell disease
People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...
National Institute for Health and Care Excellence4d
Harnessing expertise to improve patient access to innovative health technologies
New and innovative mechanisms of action are constantly being discovered and developed into medicines that tackle a broad ...
National Institute for Health and Care Excellence2d
Thousands of people with a severe dust mite allergy are set to benefit from life-changing treatment
The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...
National Institute for Health and Care Excellence2d
Olezarsen for treating familial chylomicronaemia syndrome TSID 11993
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
National Institute for Health and Care Excellence2d
Healthcare associated infections: incidence of Methicillin-resistant Staphylococcus aureus (MRSA)
This indicator covers the incidence of healthcare associated infections from Methicillin-resistant Staphylococcus aureus (MRSA). It measures outcomes that reflect the quality of care or processes ...
National Institute for Health and Care Excellence2d
Healthcare-associated infections: incidence of Clostridium difficile (C. diff)
This indicator covers the incidence of healthcare associated infections from Clostridium difficile (C. diff). It measures outcomes that reflect the quality of care or processes linked by evidence to ...
National Institute for Health and Care Excellence2d
Mortality: cancer
This indicator covers under 75 mortality rate from cancer. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator will be reviewed ...
National Institute for Health and Care Excellence2d
Mortality: liver disease
This indicator covers under 75 mortality from liver disease. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator will be reviewed ...
National Institute for Health and Care Excellence2d
Mortality: respiratory
This indicator covers under 75 mortality from respiratory disease. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator will be ...
National Institute for Health and Care Excellence2d
Mortality: cardiovascular disease
This indicator covers under 75 mortality from cardiovascular disease. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator will be ...
National Institute for Health and Care Excellence2d
Mortality: life expectancy at 75
This indicator will be reviewed using the assessment criteria in appendix B of the NICE indicators process guide when it reaches its review date or the underlying guidance is updated.